Keen in getting involved in Incremental Haemodialysis?

Why not take the survey created by Prof. C. Basile (EUDIAL Chair) - it is available here
The majority of patients on dialysis are currently treated with a fixed dose thrice-weekly haemodialysis regimen irrespective of whether or not they are starting dialysis therapy (incident) or have been receiving dialysis for some time (prevalent) and without consideration for their residual kidney function (RKF). The thrice-weekly regimen has been assumed almost as a dogma in the dialysis community. Incredibly, this schedule has been widely accepted worldwide without ever undergoing any randomised controlled trial to examine whether less frequent haemodialysis treatments would be inadequate or harmful.
Read more→

Practice patterns of fluid volume management in HD patients